Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
22/08/2025 15:49
Aug 22 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd 2348.HK: DECLARED INTERIM DIVIDEND OF HK$0.015 PER SHARE DAWNRAYS PHARMACEUTICAL (HOLDINGS) H1 REVENUE RMB 630.4 MILLION DAWNRAYS PHARMACEUTICAL (HOLDINGS) H1 NET INCOME ATTRIBUTABLE RMB 104.6 MILLION Further company coverage: 2348.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO